Study Suggests GLP-1 Drug May Significantly Lower Breast Cancer Risk
- Posted on June 2, 2026
- By Google News
- 0 Views
- 1 min read
Study Suggests GLP-1 Drug May Significantly Lower Breast Cancer Risk
June 2, 2026 — Results of an American College of Radiology-managed retrospective study involving 110,000 women presented at the 2026 ASCO Annual Meeting, shows that those who took GLP-1 medications were up to 35% less likely to develop breast cancer than those who did not take GLP-1 drugs. ACR urges funding of a large prospective study to clarify impact of these drugs on cancer incidence and prevention.
